The annual observance serves as an opportunity to raise public awareness about this rare and chronic genetic disease, caused by alterations in the CFTR gene. These alterations lead to the production of abnormally thick bodily secretions, affecting various systems and organs, particularly the lungs, pancreas, and digestive system.
Increasingly early diagnosis, more specialized care, and the development of new medications and therapies have substantially altered the natural course of the disease, significantly improving the quality of life and life expectancy for people living with cystic fibrosis.
By marking this date, SESARAM underscores the importance of early diagnosis and continuous, close, and integrated monitoring of this pathology, through the provision of differentiated, specialized healthcare tailored to the needs of users with Cystic Fibrosis throughout their lives.




